Stool for Calprotectin at Chughtai Lab

Stool for Calprotectin at Chughtai Lab

The Stool for Calprotectin test at Chughtai Lab is a highly specialized, non-invasive diagnostic laboratory investigation used to detect and monitor inflammation within the gastrointestinal tract. Calprotectin is a calcium- and zinc-binding protein complex (specifically a heterodimer of S100A8 and S100A9) that is primarily found within the cytoplasm of neutrophils, a type of white blood cell. When inflammatory processes occur in the mucosal lining of the intestines, neutrophils migrate to the site of inflammation and degranulate, releasing calprotectin directly into the intestinal lumen. Because calprotectin is highly resistant to enzymatic degradation by metabolic processes and bacterial enzymes within the gut, it remains stable in feces for several days, making it an exceptional and highly reliable fecal biomarker.

At Chughtai Lab, this test is performed using advanced quantitative immunoassay technologies, such as Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA). These state-of-the-art methodologies ensure precise measurement of fecal calprotectin levels, providing clinicians with invaluable quantitative data. The primary clinical importance of the Stool for Calprotectin test lies in its ability to differentiate between inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, and non-inflammatory, functional gastrointestinal disorders, most notably Irritable Bowel Syndrome (IBS). By utilizing this non-invasive biomarker, healthcare providers can avoid unnecessary, invasive, and expensive endoscopic procedures like colonoscopies for patients who are unlikely to have mucosal inflammation. Additionally, the test offers immense diagnostic value in monitoring disease activity, assessing therapeutic response, and predicting clinical relapses in patients already diagnosed with chronic inflammatory bowel conditions.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and reliability of the Stool for Calprotectin test results at Chughtai Lab, patients must adhere to specific preparation guidelines. Proper preparation minimizes the risk of false-positive or false-negative outcomes, which can significantly impact clinical decision-making. Please follow these instructions carefully:

• Medication Review: Patients should consult their referring physician regarding the temporary discontinuation of certain medications. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, naproxen, and high-dose aspirin, can cause mild, subclinical mucosal inflammation in the gut, leading to falsely elevated calprotectin levels. If clinically feasible, these medications should be discontinued for at least two weeks prior to sample collection.
• Proton Pump Inhibitors (PPIs): Long-term use of PPIs (e.g., omeprazole, esomeprazole) may alter the gut microbiota and lead to mild intestinal inflammation. Discuss with your doctor if you need to pause these medications before the test.
• No Active Bleeding: Do not collect a stool sample if you have active hemorrhoidal bleeding, menstrual bleeding, or significant rectal bleeding from a localized lesion, as blood contains neutrophils that will artificially elevate fecal calprotectin levels.
• Dietary Restrictions: There are no specific dietary or fasting requirements for this test. Patients may eat and drink normally prior to sample collection.
• Container Selection: Use only the sterile, leak-proof plastic container provided by Chughtai Lab. Do not use any non-medical containers, as they may contain chemical residues that interfere with the immunoassay.

During the Procedure

The Stool for Calprotectin test requires a single, fresh stool sample collected by the patient. The collection process is simple, hygienic, and can be performed in the comfort of your home. Understanding the step-by-step process ensures sample integrity:

• Step 1: Preparation of the Collection Area: Ensure that the stool sample does not come into contact with toilet water, urine, or cleaning chemicals, as these substances can dilute or degrade the calprotectin protein. You can place a clean, dry plastic wrap or a commercial stool collection paper over the toilet bowl to catch the specimen.
• Step 2: Sample Collection: Using the spoon or spatula attached to the lid of the sterile container provided by Chughtai Lab, collect a small sample of stool (approximately the size of a walnut, or about 5 to 10 grams). If the stool is liquid, collect approximately 5 to 10 milliliters of the fluid.
• Step 3: Target Specific Areas: If the stool contains visible areas of mucus, prioritize collecting from those sections, as calprotectin is highly concentrated in inflammatory mucus. However, avoid collecting gross blood if it is due to active hemorrhoids.
• Step 4: Securing the Container: Place the sample into the sterile container and screw the cap on tightly to prevent leakage. Ensure the outside of the container remains clean and uncontaminated.
• Step 5: Labeling and Transport: Clearly write your full name, age, gender, and the date and time of collection on the container label. Transport the sample to the nearest Chughtai Lab collection center as soon as possible, ideally within 2 to 4 hours of collection. If a delay is unavoidable, store the sample in a refrigerator (between 2°C and 8°C) but do not freeze it.

When is a Stool for Calprotectin Test Performed?

Differentiating IBD from IBS

Physicians frequently request a Stool for Calprotectin test when a patient presents with chronic, non-specific gastrointestinal symptoms such as abdominal pain, bloating, and altered bowel habits. Because the clinical presentations of Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) overlap significantly, this test serves as an essential screening tool. A normal calprotectin level strongly points toward a functional, non-inflammatory disorder like IBS, helping patients avoid invasive diagnostic procedures like colonoscopy and sigmoidoscopy.

Monitoring Inflammatory Bowel Disease (IBD) Activity

For patients with an established diagnosis of Crohn's disease or ulcerative colitis, the Stool for Calprotectin test is performed at regular intervals to monitor disease activity. Clinical symptoms do not always correlate perfectly with mucosal inflammation. By measuring calprotectin levels, gastroenterologists can objectively assess whether the disease is in clinical remission or if there is subclinical inflammation that may require an adjustment in medical therapy, such as optimizing doses of biologics, immunomodulators, or corticosteroids.

Evaluating Chronic Diarrhea and Abdominal Pain

Persistent or chronic diarrhea lasting more than four weeks, especially when accompanied by recurrent abdominal pain, warrants a thorough diagnostic workup. A Stool for Calprotectin test is performed to determine if the underlying cause is inflammatory. Elevated levels prompt further investigation into conditions like microscopic colitis, celiac disease, infectious colitis, or drug-induced enteropathy, guiding the clinician toward the correct diagnostic pathway.

Assessing Mucosal Healing

In modern gastroenterology, the therapeutic goal for IBD has shifted from mere symptomatic control to achieving complete mucosal healing. Mucosal healing is associated with lower relapse rates, fewer hospitalizations, and a reduced need for surgical intervention. The Stool for Calprotectin test is performed as a non-invasive surrogate marker to evaluate mucosal healing. A normalization of calprotectin levels indicates successful mucosal repair, providing reassurance to both the patient and the physician.

Investigating Unexplained Gastrointestinal Symptoms in Children

Pediatric patients presenting with recurrent abdominal pain, chronic diarrhea, poor weight gain, or growth retardation present a diagnostic challenge. Invasive endoscopic procedures require general anesthesia in children and carry inherent risks. The Stool for Calprotectin test is an excellent, non-invasive first-line screening tool in pediatric gastroenterology to rule out organic inflammatory bowel diseases before considering invasive interventions.

What Does a Stool for Calprotectin Test Detect?

The Stool for Calprotectin test is a highly sensitive indicator of intestinal inflammation. A quantitative analysis of the stool sample can detect and help differentiate a wide range of clinical findings and underlying conditions, including:

• Absence of Intestinal Inflammation: Normal calprotectin levels (typically below 50 µg/g) indicate that significant mucosal inflammation is highly unlikely, suggesting functional bowel disorders like Irritable Bowel Syndrome (IBS).
• Active Crohn's Disease: Significantly elevated calprotectin levels indicate active inflammatory processes in the small intestine or colon characteristic of Crohn's disease.
• Active Ulcerative Colitis: High levels of fecal calprotectin correlate with mucosal inflammation and ulceration restricted to the colon and rectum.
• Infectious Colitis: Bacterial gastrointestinal infections (e.g., Salmonella, Campylobacter, Shigella, Clostridioides difficile) cause acute neutrophil infiltration, resulting in elevated calprotectin.
• Microscopic Colitis: Chronic inflammatory conditions of the colon, including lymphocytic and collagenous colitis, can cause mild to moderate elevations.
• Diverticulitis: Inflammation of diverticula in the colonic wall leads to localized neutrophil activation and elevated fecal calprotectin.
• Celiac Disease: Active, untreated celiac disease with significant duodenal mucosal inflammation can cause elevated calprotectin levels.
• Colorectal Neoplasia: Large adenomatous polyps or colorectal carcinoma can cause localized mucosal inflammation and minor bleeding, leading to elevated calprotectin.
• Non-Steroidal Anti-Inflammatory Drug (NSAID) Enteropathy: Regular use of NSAIDs can cause chemical-induced mucosal erosions and mild inflammation in the small bowel.
• Food Protein-Induced Enterocolitis: Allergic gastrointestinal responses, particularly in pediatric patients, can lead to elevated inflammatory markers.
• Gastrointestinal Graft-Versus-Host Disease (GVHD): In post-transplant patients, elevated calprotectin can indicate immunological attack on the gut mucosa.
• Ischemic Colitis: Compromised blood flow to the colon leads to tissue injury, necrosis, and acute inflammatory response, elevating calprotectin.
• Radiation Proctitis: Inflammation of the rectal mucosa following radiation therapy for pelvic malignancies.
• Eosinophilic Gastroenteritis: A rare inflammatory disease characterized by eosinophilic infiltration of the GI tract.
• Response to IBD Therapy: A downward trend in sequential calprotectin measurements detects successful therapeutic intervention and mucosal healing.
• Impending IBD Relapse: Rising calprotectin levels in an asymptomatic patient can detect a subclinical flare-up weeks before clinical symptoms manifest.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its state-of-the-art diagnostic infrastructure and its commitment to delivering highly accurate results within optimal turnaround times. For specialized pathology investigations like the Stool for Calprotectin test, the typical turnaround time is within 24 to 48 hours of sample receipt at the main processing laboratory. This rapid reporting allows clinicians to make timely decisions regarding patient care, treatment adjustments, or the need for further diagnostic procedures.

Patients can easily access their diagnostic reports through Chughtai Lab's highly integrated digital ecosystem. Once the report is finalized and verified by a consultant pathologist, an automated SMS notification containing a direct download link is sent to the patient's registered mobile number. Reports can also be accessed, viewed, and downloaded via the official Chughtai Lab website portal or the user-friendly Chughtai Lab mobile application. This seamless digital access ensures that patients and their healthcare providers have critical diagnostic data at their fingertips, facilitating prompt clinical consultations.

Stool for Calprotectin Findings Overview

The following table provides a general clinical guide for the interpretation of quantitative fecal calprotectin levels. Results must always be correlated with the individual patient's clinical presentation.

Fecal Calprotectin Level (µg/g)	Clinical Interpretation	Possible Associated Conditions
< 50 µg/g	Normal / No significant inflammation	Irritable Bowel Syndrome (IBS), functional dyspepsia, healthy mucosa.
50 – 120 µg/g	Borderline / Mild inflammation	Early IBD, mild infection, recent NSAID use, resolving colitis, or treated celiac disease.
> 120 µg/g	Elevated / Active inflammation	Active Crohn's disease, active Ulcerative Colitis, infectious gastroenteritis, diverticulitis.
> 250 µg/g	Highly Elevated / Severe inflammation	Severe flare-up of IBD, severe infectious colitis, extensive mucosal damage, or colorectal neoplasia.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Stool for Calprotectin?

• Experienced Healthcare Professionals: Chughtai Lab features a team of highly qualified consultant pathologists and laboratory technologists specializing in clinical chemistry and immunology.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and convenience at every step of the diagnostic journey.
• Quality Diagnostic Services: Operating with strict adherence to international quality standards, Chughtai Lab ensures high precision and reproducibility in all test results.
• Professional Reporting: Reports are structured clearly, providing quantitative values alongside established reference ranges to assist clinicians in accurate interpretation.
• Modern Diagnostic Approach: Utilizing advanced automated immunoassay platforms minimizes human error and enhances testing efficiency.
• Comfortable Environment: All collection centers across Pakistan are designed to provide a clean, hygienic, and welcoming environment for patients.
• Convenient Location: With an extensive network of collection centers nationwide, patients can easily access diagnostic services close to home.
• Commitment to Accurate Diagnosis: Chughtai Lab maintains rigorous internal and external quality control programs to deliver trustworthy diagnostic insights.